CAMP4 Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAMP and other ETFs, options, and stocks.About CAMP
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A.
CEOJosh Mandel-Brehm
CEOJosh Mandel-Brehm
Employees55
Employees55
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees55
Employees55
CAMP Key Statistics
Market cap309.21M
Market cap309.21M
Price-Earnings ratio-2.44
Price-Earnings ratio-2.44
Dividend yield—
Dividend yield—
Average volume341.05K
Average volume341.05K
High today$6.32
High today$6.32
Low today$5.96
Low today$5.96
Open price$6.22
Open price$6.22
Volume107.47K
Volume107.47K
52 Week high$7.31
52 Week high$7.31
52 Week low$1.31
52 Week low$1.31
Stock Snapshot
With a market cap of 309.21M, CAMP4 Therapeutics(CAMP) trades at $6.32. The stock has a price-to-earnings ratio of -2.44.
On 2026-01-04, CAMP4 Therapeutics(CAMP) stock moved within a range of $5.96 to $6.32. With shares now at $6.32, the stock is trading +6.1% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 107.47K, compared to an average daily volume of 341.05K.
Over the past 52 weeks, CAMP4 Therapeutics(CAMP) stock has traded between a high of $7.31 and a low of $1.31.
Over the past 52 weeks, CAMP4 Therapeutics(CAMP) stock has traded between a high of $7.31 and a low of $1.31.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own CAMP. This list is generated using Robinhood data, and it’s not a recommendation.